N-Apt17 for COVID-19

 N-Apt17 has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed N-Apt17 in detail.
Zhang et al., Aptamer-engaged nanotherapeutics against SARS-CoV-2, Discover Nano, doi:10.1186/s11671-025-04245-3